Company Filing History:
Years Active: 2000-2001
Title: The Innovations of Shujian Wu
Introduction
Shujian Wu is a notable inventor based in Levittown, PA (US). He has made significant contributions to the field of immunology, holding a total of 4 patents. His work focuses on the development of polypeptides and polynucleotides that have potential therapeutic applications.
Latest Patents
Among his latest patents is PIGR-1, which is a member of the immunoglobulin gene superfamily. This patent discloses PIGR-1 polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. The patent also outlines methods for utilizing PIGR-1 polypeptides and polynucleotides in designing protocols for treating various conditions, including rheumatoid arthritis (RA), multiple sclerosis (MS), psoriasis, systemic lupus erythematosus (SLE), and inflammatory bowel disease (IBD). Another significant patent is PIGRL-1, which also belongs to the immunoglobulin gene superfamily. This patent details the PIGRL-1 polypeptide and polynucleotides, as well as methods for producing these polypeptides by recombinant techniques. It further describes methods for utilizing PIGRL-1 polypeptide and polynucleotides in the treatment of Hyper-IgM Immunodeficiency (HIM), X-linked Severe Combined Immunodeficiency (XSCID), and IgA deficiency (IgA-D), among others.
Career Highlights
Shujian Wu is currently employed at SmithKline Beecham Corporation, where he continues to innovate in the field of immunology. His work has the potential to impact the treatment of several autoimmune and immunodeficiency disorders.
Collaborations
He has collaborated with notable coworkers, including Raymond W Sweet and Alemseged Truneh, contributing to a dynamic research environment.
Conclusion
Shujian Wu's contributions to immunology through his patents and collaborations highlight his role as an influential inventor in the field. His work promises to advance therapeutic options for various medical conditions.